Beyond Air, Inc. (NASDAQ:XAIR) Director Robert Carey Acquires 1,000,000 Shares

Beyond Air, Inc. (NASDAQ:XAIRGet Free Report) Director Robert Carey acquired 1,000,000 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was purchased at an average cost of $0.25 per share, with a total value of $250,000.00. Following the completion of the acquisition, the director now owns 4,076,864 shares of the company’s stock, valued at $1,019,216. The trade was a 32.50 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Beyond Air Price Performance

Shares of NASDAQ XAIR traded up $0.03 during mid-day trading on Monday, hitting $0.30. The company had a trading volume of 1,110,120 shares, compared to its average volume of 1,382,954. The stock has a market cap of $20.64 million, a price-to-earnings ratio of -0.28 and a beta of 0.16. The firm’s 50 day simple moving average is $0.35 and its two-hundred day simple moving average is $0.41. Beyond Air, Inc. has a 12 month low of $0.24 and a 12 month high of $1.78.

Beyond Air (NASDAQ:XAIRGet Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative net margin of 1,730.00% and a negative return on equity of 226.01%. During the same period last year, the company posted ($0.50) earnings per share. Equities analysts forecast that Beyond Air, Inc. will post -0.79 earnings per share for the current year.

Institutional Trading of Beyond Air

Several institutional investors have recently modified their holdings of XAIR. Soros Fund Management LLC acquired a new position in Beyond Air during the third quarter worth about $573,000. Baldwin Wealth Partners LLC MA lifted its holdings in shares of Beyond Air by 721.3% during the 4th quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after buying an additional 270,500 shares during the last quarter. Geode Capital Management LLC grew its position in Beyond Air by 81.0% in the fourth quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock worth $202,000 after acquiring an additional 251,823 shares in the last quarter. Alyeska Investment Group L.P. acquired a new position in shares of Beyond Air during the 4th quarter worth $2,560,000. Finally, Balyasny Asset Management L.P. bought a new position in shares of Beyond Air during the 4th quarter valued at $1,195,000. Institutional investors and hedge funds own 31.50% of the company’s stock.

About Beyond Air

(Get Free Report)

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.

Featured Articles

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.